What You Should Know:
- Tempus, an $8B precision medicine company, announced a collaborative study with Geisinger focusing on artificial intelligence (AI) model that can accurately identify patients at increased risk of undiagnosed structural heart disease (SHD). The study addresses a critical diagnostic gap – SHD is a progressive disease that affects the valves, walls, chambers, and muscles of the heart, and causes debilitating symptoms or death, yet many patients with the disease go
Read More
Heart Disease | Transforming Heart Disease through Medical Technology for Patients
Hello Heart Raises $70M to Expand Heart Health Solutions
What You Should Know:
- Hello Heart, the only digital therapeutics company focused exclusively on heart disease, announced a $70M Series D funding round led by Stripes to support its rapid growth in the employer market
- The funding round will specifically support the increase in employer market demand for Hello Heart’s technology as a focus on heart health sharpens. The company has experienced massive growth in the employer market, doubling the number of clients in the last three
Read More
4C Medical Technologies Nabs $35M, Appoints New President and CEO
What You Should Know:
- 4C Medical Technologies, a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease raises $35.4M in Series C funding was led by MicroPort CardioFlow Medtech Corporation (HKEX:2160).
- The Company's AltaValve® would be the first MR treatment with atrial-only fixation that is designed to minimize known issues associated with current TMVR technologies,
Read More
Eko Unveils Newly Designed Heart Disease Detection App
What You Should Know:
- Eko, a digital health company advancing heart and lung disease detection, today announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease. Heart disease is the leading cause of death in the U.S., and there has not been an efficient and affordable solution to screen for heart disease at the physical exam until now.
- Eko has transformed the traditional stethoscope into an
Read More
Recora Raises $20M for Virtual Cardiac Recovery Platform
What You Should Know:
- Recora today emerged from stealth to announce $20M in Series A funding led by SignalFire with participation from Valor Equity Partners and existing investor Pear VC.
- In addition, the company while also unveiled its Cardiac Recovery Program for health systems, medical groups and health plans.
Redefining the Future of Heart Health
Recora is redesigning heart health, beginning with cardiac recovery. Cardiac rehabilitation is indicated
Read More
EarliTec Diagnostics Raises $19.5M to Advance Autism Diagnosis and Treatment in Children
What You Should Know:
- EarliTec Dx, a digital health company developing novel diagnostic and therapeutic products for children with Autism Spectrum Disorder (ASD) and early childhood vulnerabilities, today announced a $19.5 million financing led by Bernie Marcus, with participation from the Georgia Research Alliance (GRA).
- This round of financing will be used to support filing with the U.S. Food and Drug Administration (FDA) for 510K clearance, as well as commercialization of the
Read More
AliveCor Launches KardiaMobile Card, World’s First Credit-Card-Sized Personal ECG
What You Should Know:
- Today, AliveCor is launching KardiaMobile Card, the latest generation of personal electrocardiogram (ECG) technology that, at the size of the credit card, is the thinnest, lightest ECG device ever created and fits in any wallet.
- The FDA-cleared KardiaMobile Card detects six of the most common heart arrhythmias in 30 seconds – something no other personal ECG can do – making it the most important card in your wallet.
KardiaMobile Card: Instant Feedback on Heart
Read More
Caption Health, Ultromics Partner for AI-Powered Heart Disease Detection
What You Should Know:
- Caption Health and Oxford University spin-out Ultromics have teamed up to empower a broader set of healthcare providers and put heart disease detection and management tools in more hands. This is a second strategic partnership that Caption Health secured in the last three months to enable earlier disease detection and management with AI-based guidance and diagnostics.
- Together, the companies will offer the Caption AI™ software platform alongside Ultromics’ EchoGo®
Read More
Bayer, One Drop Launches AI-Enabled Cardiovascular Disease Prevention Solution
What You Should Know:
- One Drop, an AI powered chronic condition management platform, and pharma giant Bayer - their strategic partner/investor released their co-developed digital, AI-enabled, cardiovascular disease (CVD) prevention module.
- The digital-first approach to CVD prevention provides a holistic set of digital tools and coaching placing One Drop members on a healthier path by personalizing care, gathering data, and
Read More
Ultromics Raises $33M for AI-Enabled Echocardiograms to Help Clinicians Diagnose Heart Disease
What You Should Know:
- Today, Ultromics, an Oxford, England-based health-tech startup announced it has raised $33M in Series B funding led by Blue Ventures, the investing arm of Blue Cross Blue Shield, and also includes investment from Optum Ventures, GV, and Oxford Sciences.
- Born at the University of Oxford and built-in partnership with the U.K.’s NHS, Ultromics has developed the first fully automated solution for echocardiography and analysis of global longitudinal strain (GLS).
Read More
